MedPath

重庆药谷制药有限公司

Ownership
-
Established
2015-05-21
Employees
-
Market Cap
-
Website
www.ygmedvt.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

11

NMPA:11

Drug Approvals

Polyethylene Glycol Electrolytes Powder(Ⅲ)

Product Name
复方聚乙二醇电解质散(Ⅲ)
Approval Number
国药准字H20253477
Approval Date
Feb 25, 2025
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20249382
Approval Date
Nov 15, 2024
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20249278
Approval Date
Nov 5, 2024
NMPA

Ceftizoxime Sodium for Injection

Product Name
注射用头孢唑肟钠
Approval Number
国药准字H20249279
Approval Date
Nov 5, 2024
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20244641
Approval Date
Aug 5, 2024
NMPA

Potassium Chloride Granules

Product Name
氯化钾颗粒
Approval Number
国药准字H20244642
Approval Date
Aug 5, 2024
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20244356
Approval Date
Jun 28, 2024
NMPA

Potassium Chloride Injection

Product Name
氯化钾注射液
Approval Number
国药准字H20244355
Approval Date
Jun 28, 2024
NMPA

Famotidine Injection

Product Name
法莫替丁注射液
Approval Number
国药准字H20243942
Approval Date
Jun 4, 2024
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20243823
Approval Date
May 28, 2024
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.